Turkey taps into Sophia Genetics to build Data Driven Medicine capacities10.03.2016 09:40
Sophia Genetics, the global leader in Data Driven Medicine (DDM), today announced that eight additional prestigious Turkish Hospitals have adopted Sophia DDM, the most advanced clinical genomics community platform. With these additional partnerships, Sophia Genetics now provides access to its global clinical genomics community for molecular diagnosis to 50% of Turkish Hospitals.
As participants in Sophia Genetics’ clinical genomics community, the Turkish hospitals and their patients will benefit from the most advanced algorithms to detect even subtle genomic alterations in cancer genes such as base substitutions, copy number alterations, short insertions, deletions and rearrangements. In an increasing number of cases, early detection of such mutations helps oncologists recommend targeted and more effective treatments to their patients. Furthermore, early detection of these mutations can highlight the potential risk of higher susceptibility to develop hereditary cancers for instance.
Jurgi Camblong, CEO and founder of Sophia Genetics, commented: “The momentum for the adoption of our technology is expending rapidly well beyond the European Union. Our successful experience in Turkey shows that more Hospitals worldwide are able to leverage our advanced machine-learning based algorithms to diagnose hundreds of patients every day. Thanks to Sophia DDM, Turkish Hospitals now have access not only to the most advanced genomic data analytics algorithms but also to the knowledge gathered on Sophia DDM through the world’s largest clinical genomics community.”
44 new partnerships in February 2016
These partnerships are expected to pave the way for a shift toward Data Driven Medicine in Turkey as additional Hospitals, labs and clinics should soon adopt Sophia DDM in the country. The partnerships announced today in Turkey participate in Sophia Genetics’ very strong growth since the start of 2016, with 44 additional partnerships concluded in February only in Europe and beyond.